Literature DB >> 3012361

Re-routing of a secretory protein by fusion with human growth hormone sequences.

H H Moore, R B Kelly.   

Abstract

Cells with electron-dense secretory vesicles use them to store only specialized secretory products such as peptide hormones; other types of secreted proteins are externalized by an alternative, constitutive route. One possible mechanism for such segregation is that proteins destined for dense secretory vesicles contain unique 'sorting domains' that allow for selective targeting. Here, we set out to determine whether a constitutively secreted protein could be diverted to the dense secretory vesicles by attachment to a peptide hormone sequence. We made use of the ability of the mouse pituitary tumour cell, AtT-20, to correctly sort exogenous secretory proteins introduced into them by DNA transfection. We constructed a plasmid encoding a hybrid protein in which a constitutively secreted viral protein was fused to the carboxy terminus of human growth hormone (hGH). Cells expressing the hybrid protein were found to target it to dense secretory vesicles with an efficiency close to that observed for the parental hGH. These results support the hypothesis that sorting domains on peptide hormones direct their packaging into dense secretory vesicles. The results also suggest that proteins secreted by the constitutive pathway either do not contain any sorting domain, or their sorting signals can be overridden by those which direct peptide hormones.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3012361     DOI: 10.1038/321443a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  37 in total

1.  Mutant proinsulin that cannot be converted is secreted efficiently from primary rat beta-cells via the regulated pathway.

Authors:  Philippe A Halban; Jean-Claude Irminger
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

2.  Partial diversion of a mutant proinsulin (B10 aspartic acid) from the regulated to the constitutive secretory pathway in transfected AtT-20 cells.

Authors:  D J Gross; P A Halban; C R Kahn; G C Weir; L Villa-Komaroff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  Lumenal protein sorting to the constitutive secretory pathway of a regulated secretory cell.

Authors:  Roberto Lara-Lemus; Ming Liu; Mark D Turner; Philipp Scherer; Gudrun Stenbeck; Puneeth Iyengar; Peter Arvan
Journal:  J Cell Sci       Date:  2006-04-11       Impact factor: 5.285

Review 4.  Sorting and storage during secretory granule biogenesis: looking backward and looking forward.

Authors:  P Arvan; D Castle
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

Review 5.  The signal peptide.

Authors:  G von Heijne
Journal:  J Membr Biol       Date:  1990-05       Impact factor: 1.843

6.  A short domain of the plant vacuolar protein phytohemagglutinin targets invertase to the yeast vacuole.

Authors:  B W Tague; C D Dickinson; M J Chrispeels
Journal:  Plant Cell       Date:  1990-06       Impact factor: 11.277

7.  Use of a synthetic peptide antigen to generate antisera reactive with a proteolytic processing site in native human proinsulin: demonstration of cleavage within clathrin-coated (pro)secretory vesicles.

Authors:  D F Steiner; J Michael; R Houghten; M Mathieu; P R Gardner; M Ravazzola; L Orci
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

8.  Toward gene therapy for growth hormone deficiency via salivary gland expression of growth hormone.

Authors:  G Z Racz; C Zheng; C M Goldsmith; B J Baum; N X Cawley
Journal:  Oral Dis       Date:  2014-01-13       Impact factor: 3.511

9.  Secretory protein traffic. Chromogranin A contains a dominant targeting signal for the regulated pathway.

Authors:  R J Parmer; X P Xi; H J Wu; L J Helman; L N Petz
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Distinct molecular events during secretory granule biogenesis revealed by sensitivities to brefeldin A.

Authors:  C J Fernandez; M Haugwitz; B Eaton; H P Moore
Journal:  Mol Biol Cell       Date:  1997-11       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.